|1.||Kawanishi, Shosuke: 22 articles (01/2014 - 09/2003)|
|2.||Hiraku, Yusuke: 21 articles (01/2014 - 09/2003)|
|3.||Ma, Ning: 19 articles (01/2014 - 09/2003)|
|4.||Murata, Mariko: 18 articles (01/2014 - 09/2003)|
|5.||Pinlaor, Somchai: 9 articles (12/2013 - 09/2003)|
|6.||Oikawa, Shinji: 7 articles (12/2013 - 09/2003)|
|7.||Yongvanit, Puangrat: 6 articles (12/2013 - 09/2003)|
|8.||Semba, Reiji: 5 articles (09/2005 - 09/2003)|
|9.||Thanan, Raynoo: 4 articles (12/2013 - 10/2011)|
|10.||Sripa, Banchob: 4 articles (12/2013 - 09/2003)|
08/01/2010 - "On the basis of these findings, we have proposed that 8-nitroguanine could be a potential biomarker to evaluate the risk of inflammation-related carcinogenesis."
01/01/2009 - "We have found that 8-nitroguanine is formed at the sites of carcinogenesis regardless of etiology, and proposed the possibility that 8-nitroguanine is a potential biomarker to evaluate the risk of inflammation-associated carcinogenesis. "
01/01/2009 - "Development of a detection method for 8-nitroguanine would provide an insight into the mechanism of inflammation-associated carcinogenesis and the assessment of carcinogenic risk in patients with inflammatory diseases. "
01/01/2009 - "8-Nitroguanine immunoreactivity, which was observed mainly in the nuclei of stomach epithelium, increased with the severity of inflammation. "
07/01/2007 - "Thus, 8-nitroguanine is a more suitable and promising biomarker for evaluating the risk of inflammation-mediated cervical carcinogenesis than p16."
03/01/2010 - "Moreover, strong 8-nitroguanine formation in tumor tissues was closely associated with a poor prognosis. "
11/01/2007 - "Little or no immunoreactivity of 8-nitroguanine and HIF-1alpha was observed in adjacent non-tumor tissues. "
11/01/2007 - "8-Nitroguanine formation was predominantly observed in the nuclei of tumor cells and inflammatory cells in tumor tissues, while HIF-1alpha was expressed in the cytoplasm and nuclei of tumor cells. "
02/01/2007 - "In conclusion, 8-nitroguanine appears to participate in not only the initiation and promotion of MFH, but also in the progression of MFH, and could therefore be used as a promising biomarker to evaluate the prognosis of cancer patients."
11/01/2007 - "The aim of this study was to evaluate the impact of 8-nitroguanine formation and HIF-1alpha expression on the prognosis of patients with inflammation-related cancer. "
05/01/2006 - "An immunofluorescence labeling study demonstrated that 8-nitroguanine was strongly formed in gastric gland epithelial cells in gastritis patients with H. "
06/25/2004 - "A double immunofluorescence labeling study demonstrated that the level of 8-nitroguanine and 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG) apparent in gastric gland epithelium was significantly higher in gastritis patients with H. "
|4.||Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/15/2006 - "Appreciable 8-nitroguanine immunostaining was also observed in both nuclei and cytoplasm of malignant epithelial cells in squamous cell carcinoma. "
09/01/2005 - "A double immunofluorescence labeling study found that 8-nitroguanine and 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG) accumulated in oral epithelium in OLP and oral squamous cell carcinoma (OSCC) biopsy specimens, whereas little or no immunoreactivity was observed in normal oral mucosa. "
03/01/2006 - "A double immunofluorescence labeling study demonstrated that the accumulation of mutagenic 8-nitroguanine, an indicator of nitrative DNA damage, and 8-oxo-7,8-dihydro-2'-deoxyguanosine, an indicator of oxidative DNA damage, was apparently observed in the oral epithelium of patients with leukoplakia, whereas little or no immunoreactivity was observed in normal oral mucosa. "
|2.||DNA (Deoxyribonucleic Acid)
|5.||8-nitroguanosine 3',5'-cyclic monophosphate
|6.||Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)
|8.||Reactive Nitrogen Species
|9.||NF-kappa B (NF-kB)
|10.||Biological Markers (Surrogate Marker)